In vivo biodistribution of ginkgolide B, a constituent of Ginkgo biloba, visualized by MicroPET

Planta Medica

Volumn 71, Issue 7, 2005, Pages 622-627

  Suehiro, Makiko ^a,b   Simpson, Norman R ^a   Underwood, Mark D ^a   Castrillon, John ^a   Nakanishi, Koji ^a   Van Heertum, Ronald ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Ginkgo biloba; Ginkgoaceae; Ginkgolide B; In vivo biodistribution of ginkgolide B; MicroPET; Positron emission tomography

Indexed keywords

GINKGOLIDE B;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISSECTION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG STRUCTURE; GINKGO BILOBA; IN VIVO STUDY; INTESTINE; LIVER METABOLISM; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; STOMACH;

ANIMALS; DITERPENES; FLUORINE RADIOISOTOPES; GINKGO BILOBA; GINKGOLIDES; LACTONES; MALE; PHYTOTHERAPY; PLANT EXTRACTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRITIUM;

ANIMALIA; GINKGO BILOBA; GINKGOACEAE;

EID: 23644437289     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871267     Document Type: Article

References (21)

1. Curtis-Prior P, Vere D, Fray P. Therapeutic value of Gingko biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol 1996;51:535-41
2. Le Bars PL. Magnitude of effect and special approach to Ginkgo biloba extract EGb 761 in cognitive disorders. Pharmacopsychiatry 2003; 36 (Suppl 1): 544-9
3. Braquet P. Ginkgolides: chemistry, biology, pharmacology and clinical perspectives. J. R. Prous Science Publishers, Barcelona: 1988
4. Amri H, Ogwuegbu SO, Boujrad N, Drieu K, Papadopoulos V. In vitro regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginko biloba extract EGb 761 and isolated ginkgolides. Endocrinology 1996; 137: 5707-18
5. Amri H, Drieu K, Papadopoulos V. Ex vivo regulation of adrenal cortical cell steroid and protein synthesis, in response to adrenocorticotropic hormone stimulation, by Ginkgo biloba Extract Egb 761 and isolated gingkolide B. Endocrinology 1997; 138: 5415-26
6. Papadopoulos V, Widmaier EP, Amri H, Zili A, Li H, Culty M et al. In vivo studies on the role of the peripheral benzodiazepine receptor (PBR) in steroidogenesis. Endocrine Research 1998; 24: 479-87
7. Du Z-Y, Li X-Y. Effects of ginkgolides on interleukin-1, tumor necrosis factor-α and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro. Arzneim-Forsch/Drug Res 1998; 48: 1126-30
8. Cheng F, Siow YL, Karmin O. Inhibition by gingkolides and bilobalide of the production of nitric oxide in macrophages (THP-1) but not in endothelial cells (HUVEC). Biochem Biopharmacol 2001; 61: 503-10
9. Kondratskaya EL, Lishko PV, Chatterjee SS, Krishtal OA. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel. Neurochemistry International 2002; 40: 647-53
10. A receptors. J Biol Chem 2003; 278: 49279-85
11. 18F. J Labelled Compds Radiopharm 2004; 47: 485-91
12. 3H. J Labelled Compods Radiopharm 2003; 46 (Suppl 1): S214
13. Maruyama M, Terahara A, Itagaki Y, Nakanishi K. Ginkgolide I. Tetrahedron Lett, 1967: 299-302
14. Zekri O, Boudeville P, Genay P, Perly B, Braquet P, Jouenne P, Burgot J-L. Ionization constants of ginkgolide B in aqueous solution. Anal Chem 1996; 68: 2598-604
15. Fourtillan JB, Brisson AM, Girault J, Ingrand J, Decourt JP, Drieu K et al. Proprietes pharmacocietiques du bilobalide et des ginkgolides A et B chez le sujet sain après administrations intraveineuses et orales d'extrait de Ginkgo biloba (EGb 761). Therapie 1995; 50: 137-44
16. Dalenback J, Abrahamson H, Bjornson E, Fandriks L, Mattson A, Olbe L et al. Human duodenogastric reflux, retroperistalsis, and MMC. Am J Physiol 1996; 270: G113-22
17. Castedal M, Bjornson E, Gretarsdottir J, Fjalling H, Abrahamson H. Scintigraphic assessment of interdigestive duodenogastric reflux in humans: distinguishing between duodenal and biliary reflux material. Scand J Gastroenterol 2000; 35: 590-8
18. Veldhuyzen van Zanten SJO, Goldie J, Hollingsworth J, Silletti C, Richardson H, Hunt RH. Secretion of intravenously administered antibiotics in gastric juice: implication for management of Helicobacter pylon. Clin Pathol 1992; 45: 225-7
19. Rathbone BJ, Johnson AW, Wyatt JI, Heatley RV, Losowsky MS. Ascorbic acid: a factor concentrated in human gastric juice. Clininal Science 1989; 76: 237-41
20. Filep J, Herman F, & Braquet P. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat. Lipids 1991; 26: 1356-8
21. Wallace JL, Steel G, Whittle BJR, Lagente V, Vargaftic B. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Gastroenterol 1987; 93: 765-73